Catalyst Rich Pipelines - Strongest Biotech Plays For 2018


Investment across the biotech space often sees a significant amount of risk associated with pipeline success and timelines. We've established a small group of biotechs which have significant catalysts upcoming in 2018 which include partnership developments, Phase III trial data, Phase II trial data and initiation of potentially novel blockbusters in clinical trials as well as looking at the pipeline potential of larger companies.



from Biotech News